IC
IEQ Capital Portfolio holdings
AUM
$16.3B
1-Year Return
39.51%
This Quarter Return
-4.15%
1 Year Return
+39.51%
3 Year Return
+152.4%
5 Year Return
+193.99%
10 Year Return
–
AUM
$12.6B
AUM Growth
+$2.23B
(+22%)
Cap. Flow
+$2.8B
Cap. Flow
% of AUM
22.27%
Top 10 Holdings %
Top 10 Hldgs %
34.58%
Holding
1,766
New
441
Increased
782
Reduced
314
Closed
159
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$165M |
| 2 |
Roblox
RBLX
|
+$134M |
| 3 |
Apple
AAPL
|
+$115M |
| 4 |
Vanguard Total Stock Market ETF
VTI
|
+$107M |
| 5 |
Meta Platforms (Facebook)
META
|
+$94.9M |
Top Sells
| 1 |
Twilio
TWLO
|
+$30.5M |
| 2 |
Goldman Sachs
GS
|
+$27.7M |
| 3 |
SMAR
Smartsheet Inc.
SMAR
|
+$13.4M |
| 4 |
HCP
HashiCorp, Inc. Class A Common Stock
HCP
|
+$10.7M |
| 5 |
AppFolio
APPF
|
+$5.61M |
Sector Composition
| 1 | Technology | 22.27% |
| 2 | Communication Services | 17.89% |
| 3 | Financials | 10.61% |
| 4 | Consumer Discretionary | 7.51% |
| 5 | Healthcare | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Par Pacific Holdings
PARR
$1.67B
| $152K | ﹤0.01% |
+10,694
| New | +$152K |
|
1427
Leggett & Platt
LEG
$1.3B
| $152K | ﹤0.01% |
19,198
-81,479
| -81% | -$645K |
|
1428
Zentalis Pharmaceuticals
ZNTL
$107M
| $149K | ﹤0.01% |
93,920
+78,805
| +521% | +$125K |
|
1429
Hafnia
HAFN
$3.02B
| $149K | ﹤0.01% |
+35,826
| New | +$149K |
|
1430
Relay Therapeutics
RLAY
$688M
| $148K | ﹤0.01% |
+56,334
| New | +$148K |
|
1431
Fastly
FSLY
$1.14B
| $147K | ﹤0.01% |
+23,170
| New | +$147K |
|
|
CMRC
1432
Commerce.com, Inc. Series 1 Common Stock
CMRC
$370M
| $147K | ﹤0.01% |
+25,451
| New | +$147K |
|
1433
ICL Group
ICL
$7.99B
| $146K | ﹤0.01% |
25,717
+1,952
| +8% | +$11.1K |
|
1434
AGNC Investment
AGNC
$10.7B
| $145K | ﹤0.01% |
15,148
+969
| +7% | +$9.28K |
|
1435
James River Group
JRVR
$244M
| $143K | ﹤0.01% |
34,151
-6,381
| -16% | -$26.8K |
|
1436
Sleep Number
SNBR
$214M
| $142K | ﹤0.01% |
+22,433
| New | +$142K |
|
1437
Alto Neuroscience
ANRO
$105M
| $141K | ﹤0.01% |
65,189
| – | – |
|
|
RDFN
1438
DELISTED
Redfin
RDFN
| $139K | ﹤0.01% |
+15,109
| New | +$139K |
|
1439
Varex Imaging
VREX
$469M
| $138K | ﹤0.01% |
11,937
-9,075
| -43% | -$105K |
|
1440
Inogen
INGN
$231M
| $133K | ﹤0.01% |
18,678
+8,374
| +81% | +$59.7K |
|
1441
Burford Capital
BUR
$2.82B
| $132K | ﹤0.01% |
+10,000
| New | +$132K |
|
1442
Nomura Holdings
NMR
$22B
| $130K | ﹤0.01% |
21,082
+2,055
| +11% | +$12.6K |
|
1443
Ocular Therapeutix
OCUL
$2.23B
| $129K | ﹤0.01% |
17,629
| – | – |
|
1444
KalVista Pharmaceuticals
KALV
$708M
| $126K | ﹤0.01% |
+10,915
| New | +$126K |
|
1445
Mistras Group
MG
$299M
| $123K | ﹤0.01% |
+11,633
| New | +$123K |
|
1446
Biomea Fusion
BMEA
$115M
| $122K | ﹤0.01% |
+57,361
| New | +$122K |
|
1447
Mawson Infrastructure Group
MIGI
$8.42M
| $122K | ﹤0.01% |
+244,500
| New | +$122K |
|
1448
Myers Industries
MYE
$587M
| $119K | ﹤0.01% |
+10,012
| New | +$119K |
|
1449
Sally Beauty Holdings
SBH
$1.48B
| $119K | ﹤0.01% |
+13,226
| New | +$119K |
|
1450
Prospect Capital
PSEC
$1.29B
| $119K | ﹤0.01% |
+28,998
| New | +$119K |
|